Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Florence Boisnard, Christine Manson, Laurence Serradell & Denis Macina. (2023) DTaP-IPV-HB-Hib vaccine (Hexaxim): an update 10 years after first licensure. Expert Review of Vaccines 22:1, pages 1196-1213.
Read now
Read now
Markus Knuf, Marie-Laure Charkaluk, Phung Nguyen The Nguyen, Ignacio Salamanca de la Cueva, Petra Köbrunner, Lauren Mason, Maurine Duchenne & Valérie Berlaimont. (2023) Penta- and hexavalent vaccination of extremely and very-to-moderate preterm infants born at less than 34 weeks and/or under 1500 g: A systematic literature review. Human Vaccines & Immunotherapeutics 19:1.
Read now
Read now
Shuchen Wang, Monica Tafalla, Linda Hanssens & Jan Dolhain. (2017) A review of Haemophilus influenzae disease in Europe from 2000–2014: challenges, successes and the contribution of hexavalent combination vaccines. Expert Review of Vaccines 16:11, pages 1095-1105.
Read now
Read now
Articles from other publishers (21)
Emmanuel J. Vidor & John F. Modlin. 2023. Plotkin's Vaccines. Plotkin's Vaccines
890
913.e14
.
Jiyan Ma, Zhuo Li, Yinuo Sun, Zuokun Liu, Yuan Dang & Yangmu Huang. (2022) Improving Innovation and Access to Combination Vaccines for Childhood Immunization in China. International Journal of Environmental Research and Public Health 19:23, pages 15557.
Crossref
Crossref
Maria Auxiliadora Miranda-García, Marcus Hoffelner, Hagen Stoll, Dörte Ruhaltinger, Klaus Cichutek, Anette Siedler & Isabelle Bekeredjian-Ding. (2022) A 5-year look-back at the notification and management of vaccine supply shortages in Germany. Eurosurveillance 27:17.
Crossref
Crossref
Xiaoyu Wang, Na Gao, Jiana Wen, Jingyan Li, Yan Ma, Mingbo Sun, Jiangli Liang & Li Shi. (2021) Immunogenicity of a Candidate DTacP-sIPV Combined Vaccine and Its Protection Efficacy against Pertussis in a Rhesus Macaque Model. Vaccines 10:1, pages 47.
Crossref
Crossref
Stephen Jarrett, Sonia Pagliusi, Rachel Park, Taufik Wilmansyah, Suresh Jadhav, Patricia Correa Santana, K.R. Krishnamurthy & Lingjiang Yang. (2021) The importance of vaccine stockpiling to respond to epidemics and remediate global supply shortages affecting immunization: strategic challenges and risks identified by manufacturers. Vaccine: X 9, pages 100119.
Crossref
Crossref
Jiří Jaromír Klemeš, Peng Jiang, Yee Van Fan, Awais Bokhari & Xue-Chao Wang. (2021) COVID-19 pandemics Stage II – Energy and environmental impacts of vaccination. Renewable and Sustainable Energy Reviews 150, pages 111400.
Crossref
Crossref
Emily A. Voigt, Jasmine Fuerte-Stone, Brian Granger, Jacob Archer & Neal Van Hoeven. (2021) Live-attenuated RNA hybrid vaccine technology provides single-dose protection against Chikungunya virus. Molecular Therapy 29:9, pages 2782-2793.
Crossref
Crossref
Raquel Cid & Jorge Bolívar. (2021) Platforms for Production of Protein-Based Vaccines: From Classical to Next-Generation Strategies. Biomolecules 11:8, pages 1072.
Crossref
Crossref
Suthira Taychakhoonavudh. 2020. Global Pharmaceutical Policy. Global Pharmaceutical Policy
309
330
.
E. Chiappini, C. Petrolini, C. Caffarelli, M. Calvani, F. Cardinale, M. Duse, A. Licari, S. Manti, A. Martelli, D. Minasi, M. Miraglia Del Giudice, GB. Pajno, C. Pietrasanta, L. Pugni, MA. Tosca, F. Mosca & GL. Marseglia. (2019) Hexavalent vaccines in preterm infants: an update by Italian Society of Pediatric Allergy and Immunology jointly with the Italian Society of Neonatology. Italian Journal of Pediatrics 45:1.
Crossref
Crossref
Yahiya Y. Syed. (2019) DTaP-IPV-HepB-Hib Vaccine (Hexyon®): An Updated Review of its Use in Primary and Booster Vaccination. Pediatric Drugs 21:5, pages 397-408.
Crossref
Crossref
Kevin Markey, Catpagavalli Asokanathan & Ian Feavers. (2019) Assays for Determining Pertussis Toxin Activity in Acellular Pertussis Vaccines. Toxins 11:7, pages 417.
Crossref
Crossref
Zoltán Kis, Maria Papathanasiou, Raul Calvo‐Serrano, Cleo Kontoravdi & Nilay Shah. (2019) A model‐based quantification of the impact of new manufacturing technologies on developing country vaccine supply chain performance: A Kenyan case study. Journal of Advanced Manufacturing and Processing 1:3.
Crossref
Crossref
Laxmikant Kadam, Krunal Patel, Manish Gautam, Shrikant Thorat, Prathamesh Kale, Arvind Kumar Ghule, Akansha Gairola, Harish Rao, Yojana Shinde, Umesh Shaligram & Sunil Gairola. (2019) Development and validation of magnetic bead pentaplex immunoassay for simultaneous quantification of murine serum IgG antibodies to acellular pertussis, diphtheria and tetanus antigens used in combination vaccines. Methods 158, pages 33-43.
Crossref
Crossref
V. A. Shevtsov, Yu. V. Olefir, V. A. Merkulov, V. P. Bondarev, I. N. Indikova, E. E. Evreinova, A. V. Rukavishnikov, L. M. Khantimirova & D. V. Gorenkov. (2019) Post-approval Variations to Dossiers for Vaccines: Analysis of Regulatory and Methodological Approaches Used in the Russian Federation and Abroad. The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products 9:1, pages 41-48.
Crossref
Crossref
Federico Martinón-Torres, Javier Diez-Domingo, Emmanuel Feroldi, Emilia Jordanov, Siham B’Chir & Xavier Da Costa. (2019) Evaluation of a Hexavalent-Pentavalent-Hexavalent Infant Primary Vaccination Series Followed by a Pentavalent Booster Vaccine in Healthy Infants and Toddlers. Pediatric Infectious Disease Journal 38:3, pages 317-322.
Crossref
Crossref
Zoltán Kis, Robin Shattock, Nilay Shah & Cleo Kontoravdi. (2018) Emerging Technologies for Low‐Cost, Rapid Vaccine Manufacture. Biotechnology Journal, pages 1800376.
Crossref
Crossref
B. Soubeyrand. (2018) De la fabrication d’un vaccin à sa mise à disposition en pharmacie. Revue des Maladies Respiratoires 35:10, pages 1005-1019.
Crossref
Crossref
Claudia Mueller, Ulrike Altenburger & Silke Mohl. (2018) Challenges for the pharmaceutical technical development of protein coformulations. Journal of Pharmacy and Pharmacology 70:5, pages 666-674.
Crossref
Crossref
Rebecca Sheets. 2018. Fundamentals of Biologicals Regulation. Fundamentals of Biologicals Regulation
119
128
.
Stanley Plotkin, James M. Robinson, Gerard Cunningham, Robyn Iqbal & Shannon Larsen. (2017) The complexity and cost of vaccine manufacturing – An overview. Vaccine 35:33, pages 4064-4071.
Crossref
Crossref